Atomoxetine Azure 10 mg hard capsules
Authorisation PA22871/034/001 · Azure Pharmaceuticals Ltd.
- Licence holder
- Azure Pharmaceuticals Ltd. (all products →)
- Active substance
- Atomoxetine hydrochloride
- Clinical trials
- 3 clinical trials →
- Dosage form
- Capsule, hard
- Route of administration
- Oral use
- ATC code
- N06BA09
- First authorised
- 08/05/2026
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Atomoxetine hydrochloride: supply and approvals
15 authorised products on the HPRA list contain Atomoxetine hydrochloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- ADHD medicines: Shortage ongoing, first published 18 Dec 2023
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- 10 supply notices, e.g. Atomoxe - 1 A Pharma 60 mg Hartkapseln (31 Jul 2024 to 30 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for less than a year (since 8 May 2026). The HPRA list marks it as not marketed: it is licensed but the holder has not reported it as on sale.
Other medicines with Atomoxetine hydrochloride in Ireland
13 other products on the HPRA list contain Atomoxetine hydrochloride, from 2 licence holders; 7 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Atomoxetine Accord 10 mg Hard Capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Accord 100 mg Hard Capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Accord 18 mg Hard Capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Accord 25 mg Hard Capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Accord 40 mg Hard Capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Accord 60 mg hard capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Accord 80 mg hard capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Atomoxetine Azure 100 mg hard capsules | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Not marketed |
| Atomoxetine Azure 18 mg hard capsules | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Not marketed |
| Atomoxetine Azure 25 mg hard capsules | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Not marketed |
| Atomoxetine Azure 40 mg hard capsules | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Not marketed |
| Atomoxetine Azure 60 mg hard capsules | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Not marketed |
The licence holder
Azure Pharmaceuticals Ltd. holds 45 products on the HPRA list, with 23 different active substances; 21 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.